Matches in Wikidata for { <http://www.wikidata.org/entity/Q90228075> ?p ?o ?g. }
- Q90228075 description "2018 nî lūn-bûn" @default.
- Q90228075 description "2018年の論文" @default.
- Q90228075 description "2018年学术文章" @default.
- Q90228075 description "2018年学术文章" @default.
- Q90228075 description "2018年学术文章" @default.
- Q90228075 description "2018年学术文章" @default.
- Q90228075 description "2018年学术文章" @default.
- Q90228075 description "2018年学术文章" @default.
- Q90228075 description "2018年學術文章" @default.
- Q90228075 description "2018年學術文章" @default.
- Q90228075 description "2018年學術文章" @default.
- Q90228075 description "2018年學術文章" @default.
- Q90228075 description "2018年學術文章" @default.
- Q90228075 description "2018년 논문" @default.
- Q90228075 description "article científic" @default.
- Q90228075 description "article scientific" @default.
- Q90228075 description "article scientifique" @default.
- Q90228075 description "articol științific" @default.
- Q90228075 description "articolo scientifico" @default.
- Q90228075 description "artigo científico" @default.
- Q90228075 description "artigo científico" @default.
- Q90228075 description "artigo científico" @default.
- Q90228075 description "artikel ilmiah" @default.
- Q90228075 description "artikull shkencor" @default.
- Q90228075 description "artikulong pang-agham" @default.
- Q90228075 description "artykuł naukowy" @default.
- Q90228075 description "artículo científico publicado en 2018" @default.
- Q90228075 description "artículu científicu" @default.
- Q90228075 description "bilimsel makale" @default.
- Q90228075 description "bài báo khoa học" @default.
- Q90228075 description "naučni članak" @default.
- Q90228075 description "scienca artikolo" @default.
- Q90228075 description "scientific article published on 05 August 2018" @default.
- Q90228075 description "scientific article published on 5 August 2018" @default.
- Q90228075 description "scientific article published on 5 August 2018" @default.
- Q90228075 description "teaduslik artikkel" @default.
- Q90228075 description "tieteellinen artikkeli" @default.
- Q90228075 description "tudományos cikk" @default.
- Q90228075 description "vedecký článok" @default.
- Q90228075 description "vetenskaplig artikel" @default.
- Q90228075 description "videnskabelig artikel udgivet 5. august 2018" @default.
- Q90228075 description "vitenskapelig artikkel" @default.
- Q90228075 description "vitskapeleg artikkel" @default.
- Q90228075 description "vědecký článek" @default.
- Q90228075 description "wetenschappelijk artikel" @default.
- Q90228075 description "wissenschaftlicher Artikel" @default.
- Q90228075 description "επιστημονικό άρθρο" @default.
- Q90228075 description "мақолаи илмӣ" @default.
- Q90228075 description "наукова стаття, опублікована в серпні 2018" @default.
- Q90228075 description "научна статия" @default.
- Q90228075 description "научная статья" @default.
- Q90228075 description "научни чланак" @default.
- Q90228075 description "научни чланак" @default.
- Q90228075 description "מאמר מדעי" @default.
- Q90228075 description "مقالة علمية نشرت في 5 أغسطس 2018" @default.
- Q90228075 description "৫ আগস্ট ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q90228075 description "บทความทางวิทยาศาสตร์" @default.
- Q90228075 description "სამეცნიერო სტატია" @default.
- Q90228075 name "Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy" @default.
- Q90228075 name "Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy" @default.
- Q90228075 type Item @default.
- Q90228075 label "Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy" @default.
- Q90228075 label "Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy" @default.
- Q90228075 prefLabel "Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy" @default.
- Q90228075 prefLabel "Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy" @default.
- Q90228075 P1433 Q90228075-0DD25DF8-97B6-455F-8BAF-1453E51379B0 @default.
- Q90228075 P1476 Q90228075-AE418126-02E3-48CF-AD97-1A877B488D41 @default.
- Q90228075 P2093 Q90228075-116AF000-29F0-4A3A-B058-89B15B62866E @default.
- Q90228075 P2093 Q90228075-37EBDDE3-1A4C-4472-BA2F-77C477E5E3F2 @default.
- Q90228075 P2093 Q90228075-4FEE6695-E753-4925-933F-4C5C70970AE2 @default.
- Q90228075 P2093 Q90228075-798F5B37-CACE-4691-A4C7-231292EB7173 @default.
- Q90228075 P2093 Q90228075-CC39C7E3-D199-4876-A61C-88162AF8F1BA @default.
- Q90228075 P2093 Q90228075-E1DFA840-0F22-4C4F-8F80-61716433E7A1 @default.
- Q90228075 P2093 Q90228075-F8D98928-E151-493C-8FA5-524C6A085569 @default.
- Q90228075 P2860 Q90228075-BB47C133-DDF9-4772-B66A-73CD2FE19D15 @default.
- Q90228075 P304 Q90228075-05132040-ECA8-47B5-9675-FF227EC94A43 @default.
- Q90228075 P31 Q90228075-3D05A318-4381-4194-B9D8-6E4AC7E89F8E @default.
- Q90228075 P356 Q90228075-1AA9ADAC-B141-418B-9E52-93F84505ED91 @default.
- Q90228075 P433 Q90228075-B9EB5490-7E4A-4FF8-9AD0-09F907D0D2D7 @default.
- Q90228075 P478 Q90228075-ADCFAB55-8565-4579-B1EF-E16E8BA58A68 @default.
- Q90228075 P577 Q90228075-C9D04ADA-CBF0-4A1D-93DA-029226077063 @default.
- Q90228075 P698 Q90228075-2B60A50C-5390-4507-BF03-A5B1F6417C98 @default.
- Q90228075 P921 Q90228075-87CF051A-2BD4-4DBE-B503-7BA6A44E0BEE @default.
- Q90228075 P921 Q90228075-9BAE20CD-7AFE-4F0D-B587-30CADAEB9224 @default.
- Q90228075 P356 03007995.2018.1501351 @default.
- Q90228075 P698 30009647 @default.
- Q90228075 P1433 Q5195063 @default.
- Q90228075 P1476 "Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy" @default.
- Q90228075 P2093 "Antonio Nakasato" @default.
- Q90228075 P2093 "Briana Ndife" @default.
- Q90228075 P2093 "François Laliberté" @default.
- Q90228075 P2093 "Mei Sheng Duh" @default.
- Q90228075 P2093 "Raluca Ionescu-Ittu" @default.
- Q90228075 P2093 "Rebecca Burne" @default.
- Q90228075 P2093 "Sameer R Ghate" @default.
- Q90228075 P2860 Q27860760 @default.
- Q90228075 P304 "2169-2176" @default.
- Q90228075 P31 Q13442814 @default.
- Q90228075 P356 "10.1080/03007995.2018.1501351" @default.
- Q90228075 P433 "12" @default.